India's first homegrown COVID-19 shot wins WHO emergency use listing

Health Health Headlines News

The World Health Organization (WHO) on Wednesday said it had approved Indian drugmaker Bharat Biotech's COVID-19 vaccine for emergency use, paving the way for the homegrown shot to be accepted as a valid vaccine in many poor countries. The emergency use listing would allow Bharat Biotech to ship the shot known as Covaxin to countries that rely on WHO guidance for their regulatory decisions. The WHO tweet its technical advisory group had ruled that Covaxin's benefits significantly outweighed the risks and that it met WHO standards for protection against COVID-19.